Showing results (1301-1310 of 1,449) with videos related to

Sort By:
Pageof 145
Trials|March 3, 2026
Continuum of care in hospitalized patients with opioid or stimulant use disorder and infectious complications of drug use-substance use/infectious disease integrated clinic compared to treatment as usual to prevent infection-related readmission (CHOICE-STAR): a study protocol for an effectiveness-implementation randomized controlled trialElana S Rosenthal, Marie-Claude C Lavoie, Edward Traver, et al.
Frontiers in Immunology|April 23, 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics ToolsAnne S De Groot, Leonard Moise, Frances Terry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid TumorsKim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
The Journal of Experimental Medicine|April 11, 2025
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infectionDiana Muñoz Sandoval, Florian A Bach, Alasdair Ivens, et al.
Heart Rhythm|April 9, 2026
Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or FlutterJohn M Pfeifer, Greg Lee, Sushravya Raghunath, et al.
The International Journal on Drug Policy|August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT studyAnnabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
Lancet (London, England)|July 26, 2018
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trialDaniel J Wallace, Richard A Furie, Yoshiya Tanaka, et al.
MMWR. Morbidity and Mortality Weekly Report|April 5, 2014
Notes from the field: multistate outbreak of listeriosis linked to soft-ripened cheese--United States, 2013Mary J Choi, Kelly A Jackson, Carlota Medus, et al.
MMWR. Morbidity and Mortality Weekly Report|October 24, 2024
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages - United States, May 2023-September 2024Kevin C Ma, Juan Castro, Anastasia S Lambrou, et al.
Pageof 145